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The extent of epidermal fatty acid oxygenase activa-
tion in non-psoriatic dermatoses and the nature of 
these oxygenases are not known. The monohydroxy-
lated fatty acid derivatives produced in vivo and 
trapped in skin scales or produced in vitro by oxyge-
nases preserved in scales were analyzed by high per-
formance liquid chromatography in 10 patients with 
non-psoriatic dermatoses. Evidence for 15-lipoxyge-
nase activation included the finding of 15(S)-hy-
droxyeicosatetraenoic acid (HETE) in scales from 
seven patients and the production of 15(S)_[14C]HETE 
and 13(S)-[14C]hydroxyoctadecadienoic acid (HODE) 
during scale incubations, respectively, with [14C]ar_ 
achidonic and C4 C]linoleic acid. Evidence for the 
activation of an arachidonic acid 12(R)-oxygenase 
included the finding of 12(R)-HETE in scales from 
eight patients and the production of 12(R)-[14C]HETE 
esional psoriatic epidermis contains elevated levels of 
free arachidonic acid and of its eicosanoid derivatives, 
leukotriene B4, 12-hydroxyeicosatetraenoic acid 
(HETE), and 15-HETE [1-3]. Because leukotriene B4 
and 12-HETE are biologically active as chemoattrac-
tants at concentrations found in lesional epidermis, a possible role 
for these compounds in the pathogenesis of psoriasis has been 
postulated [4]. Levels of hydroxylated derivatives of linoleic acid, 
including 13-hydroxyoctadecadienoic acid (13-HODE) and 
9-HODE, actually exceed those of any eicosanoid in psoriatic 
epidermis [2,3,5]. These compounds are present in psoriatic scale 
extracts in both free and esterified form [5], suggesting their 
formation early in the epidermal cell cycle [6]. The biologic 
activities of these linoleic acid derivatives are less clearly defined 
than those of the eicosanoids. 
There are few published data as to the specificity of the mono-
hydroxylated fatty acid derivatives found in psoriatic skin scales. In 
particular, the finding of 12(R)-HETE in psoriatic skin scales has 
not been reported in other dermatoses [7]. Determination of the 
occurrence of these fatty acid derivatives in dermatoses other than 
psoriasis is an essential first step in correlating their in vivo produc-
Manuscript received July 6, 1994; revised September 22, 1994; accepted 
for publication September 30, 1994. 
Reprint requests to: Dr. Alan Baer, Division of Rheumatology, VA 
Medical Center, 3495 Bailey Avenue, Buffalo, NY 14215. 
Abbreviations: HODE, hydroxyoctadecadienoic acid; 9-HODE, 9-
hydroxyoctadeca-1 OE, 12Z-dienoic acid; 13-HODE, 13-hydroxyoctadeca-
9Z,l1E-dienoic acid. 
during scale incubations with [14C]arachidonic acid. 
13-HODE was the predominant fatty acid derivative 
present in scale extracts; its lack of enantiopurity 
(mean SIR = 3.1) and the substantial formation of 
9-HODE (mean SIR = 0.6; 9/13-HODE = 0.43) suggest 
its derivation from 15-lipoxygenase and a second 
oxygenase. The levels of15(S)-HETE and 12(R)-HETE 
had a 125- to 144-fold range and were highest in 
scales from a patient with erythroderma and in three 
psoriatic scale samples similarly analyzed. These 
findings indicate that 15-lipoxygenase, most likely of 
keratinocyte origin, and an arachidonic acid 12(R)oxy-
genase of unknown type and cell origin are activated 
in diverse dermatoses. Key words: eicosanoidslarachido-
nate 15-lipoxygenaselhydroxyeicosatetraenoic acidsllinoleic 
acids. ] Invest Dermatol 104:251-255, 1995 
tion with the pathogenesis of skin diseases marked by epidermal 
inflammation and/or hyperproliferation. We have demonstrated 
previously that two separate fatty acid oxygenase activities are 
preserved in psoriatic skin scales [8]. One is an w-6 oxygenase with 
strict S-stereospecificity, consistent with the activity of 15-lipoxy-
genase, and the other is that of an arachidonic acid 12(R)oxygenase. 
In the current study, we sought the same enzyme activities in skin 
scales from patients with scaling dermatoses other than psoriasis to 
provide additional evidence of the activation of these oxygenases in 
non-psoriatic skin disease. We defined the stereochemistry of the 
monohydroxylated fatty acid derivatives formed during in vitro 
incubation of select scale samples with radiolabeled exogenous 
substrate as well as those formed in vivo from endogenous arachi-
donic acid or linoleic acid. The chirality of these monohydroxylated 
fatty acid derivatives provided important evidence as to the type of 
oxygenase involved in their production. Evidence is provided for 
the activation of 15-lipoxygenase and an arachidonic acid 12(R)-
oxygenase of unknown type in a variety of scaling dermatoses. 
MATERIALS AND METHODS 
Reagents [1-14C]arachidonic acid (58.3 mCi/mmol) and [1-14C]linoleic 
acid (54 mCilmmol) were purchased from Amersham (Arlington Heights, 
IL). Racemic 15-HETE and racemic 12-HETE standards were generated 
from [1-14C]-labeled or unlabeled arachidonic acid in a reaction with 
hydrogen peroxide and cupric ions [9] to yield the hydroperoxy com-
pounds, which then were reduced with sodium borohydride. Racemic 
13-[1-14C]hydroxyocta-9 Z, 11 E-dienoic acid and racemic 9_[1_14C]hy_ 
droxyocta-10E,12Z-dienoic acid were prepared by air auto-oxidation of 
[1-14C]linoleic acid. These racemic derivatives of[14C]arachidonic acid and 
[14C]linoleic acid were purified with reversed- and straight-phase high 
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performance liquid chromatography (HPLC) before use. Unlabeled 13(S)-
HODE, 15(S)-HETE, and 12(S)-HETE standards were purchased from 
Biomol Research Laboratories (Plymouth Meeting, PA). Racemic 13-
HODE and racemic 9-HODE standards were purchased from Cayman 
Chemical Co. (Ann Arbor, MI). The methyl esters of these arachidonic acid 
and linoleic acid derivatives were prepared using ethereal diazomethane. All 
solvents were of HPLC grade. 
Human Material Scales were obtained from lesional skin of 10 patients 
with various non-psoriatic dermatoses . The dermatoses included erythro-
derma associated with a drug reaction, with cutaneous T -cell lymphoma, or 
with primary lung cancer; seborrheic dermatitis; discoid lupus erythemato-
sus; psoriasiform eruption of subacute lupus erythematosus; dermatitis 
secondary to tinea pedis; pemphigus foliaceus; congenital ichthyosis; and 
desquamation following first-degree sunburn. In addition, scales were 
obtained from three patients with psoriasis vulgaris and analyzed concur-
rently with the scale samples from patients with non-psoriatic dermatoses. 
The scales were obtained by gentle abrasion of the lesional skin with a 
scalpel blade. The scales were stored at - 80°C until use. 
Lipid Extraction The skin scales (54-1855 mg) were lyophilized, 
weighed, and then extracted for 1 h at 37°C in each of three chloroform-
methanol mixtures (2:1, 1:1, and 1:2, v/v) [10], each mixture being 
acidified by the addition of glacial acetic acid (10 /-LlIml). A fourth 
extraction consisted of chloroform-methanol, 1:1, followed by water (0.8 
vol) and 2.0 M ammonium formate , pH 3.2 (0.1 vol). The combined 
organic extracts from each sample were dried en vacuo and then treated by 
the anhydrous methanolic NaOH method of Kates [11] to transesterify 
quantitatively all esterified fatty acids and their derivatives to their respec-
tive methyl esters, while preserving intact the free fatty acids and their 
derivatives. A single modification was made to partition nonesterified fatty 
acids and their hydroxylated derivatives into the organic layer: after the 
addition of water to separate the phases, 100 /-LI of2 M ammonium formate 
buffer, pH 3.2, were added. After washing with methanol-water, 10:9, 
saturated with chloroform, the lower organic phase was dried en Ilacuo. The 
quantity of extracted lipid was determined gravimetrically. The average 
recovery of an internal standard, prostaglandin B2 , with this extraction 
procedure was 55%. The extracted lipids were reconstituted in a mobile 
phase consisting of methanol-water-acetic acid , 80:20:0.1, to separate the 
monohydroxylated derivatives of arachidonic acid and linoleic acid . 
Oxygenase Assay Skin scales, 79-135 mg, were hydrated in 1-2 ml 
medium 199 with 40 mM N-2-hydroxyethylpiperazine-N ' -2-ethanesul-
fonic acid buffer, pH 7.6. The scales then were incubated with either 
[1-14C]arachidonic acid (2 /-LCi, 34 /-LM) or [1-14C]linoleic acid (2 /-LCi, 36 
/-LM) in the presence of 4.8% ethanol for 1 h at 37°C . The incubation was 
terminated by snap-freezing the reaction vial in liquid nitrogen. The sample 
was lyophilized and subsequently extracted with methanol-chloroform 
(1:1), followed by water (0.8 vol) and 2.0 M ammonium formate , pH 3.2 
(0.1 vol). 
HPLC HPLC was performed isocratically on a Hewlett-Packard 1090 
liquid chromatograph. This instrument is equipped with a diode array 
spectrophotometer and a computer for on-line display and storage of 
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ultraviolet spectra and absorbance data. The HPLC runs were monitored at 
a wavelength of 236 nm. A Radiomatic Flo-One A-140 (Radiomatic 
Instruments and Chemical Co., Inc., Tampa, FL) radioactivity detector was 
used, when needed, for concurrent measurement ort4c in the outflow from 
the HPLC spectrophotometer. An interface between the radioactivity 
detector and the Hewlett-Packard Chern-Station computer permitted stor-
age of the radioactivity data for subsequent analysis. Software programs 
were used to calculate the quantities of oxygenase products with conjugated 
diene structures by measurement of the area beneath the peak height at a 
given Amax. A molar extinction coefficient of 23 ,000 M - 1 . cm - 1 was used in 
these calculations [12]. For the purposes of quantitation, peak integration 
was performed on compounds purified by two prior chromatographic steps 
and then resolved with chiral-phase chromatography. The recovery of the 
hydroxylated fatty acid derivatives during the sequential chromatographic 
steps averaged 76%. The quantitation was corrected for the combined losses 
that occurred during lipid extraction and during the sequential chromato-
graphic analyses . A compound was judged to be racemic if the amounts of 
its two enantiomers did not differ by more than 10%. All chromatograms 
shown in the figures are reproduced directly from the HPLC computer 
plots. 
Reversed-Phase HPLC Reversed-phase HPLC was performed isocrati-
cally using Hewlett-Packard 5 /-LM ODS-Hypersil columns, 200 mm X 4.6 
mm in internal diameter, with a flow rate of 0.4 mllmin. 
Straight-Phase HPLC Straight-phase HPLC was performed isocrati-
cally using a Microsorb 5 /-LM SI column (Rainin Instrument Co., Woburn, 
MA), 250 mm X 4.6 mm in internal diameter, with a flow rate of 0.4 
mllmin. Straight-phase chromatography was used routinely as an additional 
purification step before chiral-phase chromatography and as a means to 
resolve the principal monohydroxylated derivatives of linoleic acid, 13-
HODE and 9-HODE, which co-migrate during the initial reversed-phase 
chromatographic step. 
Stereochemical Analyses Chiral-phase HPLC was performed on two, 
250 mm X 4.6 mm internal diameter, Bakerbond straight-phase chiral 
HPLC columns in series (dinitrobenzoyl phenylglycine coupled ionically 
with aminopropyl residues; ].T. Baker Inc. , Phillipsburg, NJ). The mobile 
phase for this straight-phase HPLC consisted of hexane:isopropanol, 1000: 
15. The 15-C 4 C]HETE and 12-C 4 C]HETE generated during in vitro 
incubations of skin scales with C 4C]arachidonic acid were chromatographed 
on the same columns using a mobile phase of hexane:isopropanol, 1000:4. 
The eluate from the dUral HPLC columns was monitored for ultraviolet 
absorbance at 236 nm and for radioactivity where appropriate. Retention 
times varied slightly from run to run on the chiral-phase columns. Accord-
ingly, the identity and chirality of the compounds were confirmed in all 
cases by performing mixing studies in which synthetic methyl ester stan-
dards were added to the methyl esters of the material originally extracted 
from the skin scales. 
Statistical Analysis The data are reported as mean ± SEM. Significant 
differences between experimental groups were determined by the two-
tailed unpaired t test. Statistical significance was defined as p < 0.05. 
Table I. Monohydroxylated Arachidonic and Linoleic Acid Derivatives Are Present in Skin-Scale Samples From 13 
Patients With Diverse Dermatoses 
15-HETE" 
Diagnosis (ng/mg Lipid) 
Erythroderma/underlying lung cancer 101 
Erythroderma/ cutaneous T-cell lymphoma 31 
Erythroderma/ drug reaction 31 
Dermatitis/tinea pedis N-de{ 
Discoid lupus 7 
Seborrheic dermatitis 7 
Subacute cutaneous lupus 0.7 
Pemphigus foliaceus 1.2 
Desquamation/ sunburn N-det 
Congenital ichthyosis N-det 
Psoriasis 70 
Psoriasis 60 
Psoriasis 48 
a lS-HETE tereochemistry: all S in each sample in which it wa detected . 
b 12-HETE stereochemistry: all R in each sample in which it was detected. 
12-HETEb 
(ng/mg Lipid) 
127 
48 
22 
5 
7 
29 
2 
7 
N-det 
N-det 
250 
151 
209 
< N-det, not detected; blank spaces indicate measurements that were not made. 
13-HODE 9-HODE 
ng/mg Lipid SIR Ratio ng/mg Lipid SIR Ratio 
1075 5.6 144 0.5 
269 2.4 84 0.4 
231 6.0 29 0.7 
125 31 
84 3.5 22 0.6 
67 2.3 31 0.3 
19 1.4 7 0.3 
17 1.9 10 0.4 
5 5.2 1 0.8 
5 1.4 5 0.7 
1320 1.7 361 0.4 
820 2.0 224 0.4 
543 1.5 188 0.4 
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RESULTS 
The w-6 derivative of arachidonic acid, 15-HETE, was detected in 
free (non-esterified) form in the lipid extracts of skin scales from 
seven ofl0 patients with non-psoriatic dermatoses (26 ± 14 ng/mg 
scale lipid, mean ± SEM) and from the three patients with psoriasis 
(59 ± 6 ng/mg scale lipid, mean ± SEM). This difference in 
average levels was not statistically significant because of the wide 
range of 15-HETE concentrations. 15-HETE was not detected in 
the scale samples from the patients with tinea pedis, first-degree 
sunburn, or congenital ichthyosis (Table I). In all scale samples in 
which it was detected, the 15-HETE was exclusively the S-
enantiomer (data not shown). 
12-HETE was identified in free form in eight of the lipid extracts 
of skin scales from patients with non-psoriatic dermatoses (31 ± 15 
nglmg scale lipid, mean ± SEM) and in each of the three scale 
extracts from the patients with psoriasis (203 ± 29 ng/mg scale 
lipid, mean ± SEM). This difference in levels was statistically 
significant (p = 0.0002). This compound could not be identified in 
the scale samples from either the patient with congenital ichthyosis 
or the patient with sunburn. The 12-HETE was exclusively the 
R-enantiomer in each of the samples in which it was detected (data 
not shown). 
To evaluate oxygenase activity that had been preserved in the 
scales, samples from patients with subacute lupus erythematosus 
and with erythroderma associated with cutaneous T -cell lymphoma 
were incubated in vitro with [14C]arachidonic acid. In each of these 
incubations, the principal radioactive products were 15-[14C]HETE 
and 12-e 4C]HETE (Fig 1). The 15-HETE was methylated to yield 
the corresponding methyl ester, and its chirality was analyzed by 
chiral-phase HPLC. The experimentally derived 15-e4C]HETE 
methyl ester co-eluted with the S-enantiomer of racemic 15-
e4C]HETE methyl ester ~tandard, thereby establishing that 15(S)-
[14C]HETE was the original product formed in vitro during incu-
bation of the scales with exogenous [14C]arachidonic acid (Fig 2). 
On chiral-phase HPLC, the experimentally derived 12-C4C]HETE, 
converted to its methyl ester, co-eluted with the R-enantiomer of 
racemic 12-[14C]HETE methyl ester standard (Fig 2). Thus, 12(R)-
C4C]HETE was the original product formed in vitro during incu-
bation of the scales with exogenous C 4C]arachidonic acid. 
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Figure 1. The activities of two fatty acid oxygenases are preserved 
in skin scales. The radiolabeled products of the incubation of skin scales 
with C4C]arachidonic acid or C4C]linoleic acid are shown, respectively, in 
the upper and lower reversed-phase HPLC radiochromatograms. The incu-
bation with [14C]arachidonic acid was performed using scales from a patient 
with erythroderma associated with cutaneous T-cell lymphoma. The two 
major peaks of radioactivity in the upper chromatogram co-eluted with 
authentic 15-C4C]HETE (22.5 min) and 12-[14C]HETE (24.5 min) stan-
dards. The incubation with [14C]linoleic acid was performed using scales 
from a patient with erythroderma associated with a drug reaction. The 
major peak of radioactivity at 21.5 min co-eluted with authentic 13-
[14C]HODE and 9-[14C]HODE. 
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Figure 2. The radiolabeled 15-HETE and 12-HETE produced in vitro 
by skin scales have S- and R-stereospeci:6.city. respectively. The 
methyl esters of the radiolabeled 15-C 4C]HETE and 12-C 4C]HETE pro-
duced in the incubation of C4C]arachidonic acid with skin scales from a 
patient with cutaneous T-cell lymphoma were resolved by straight-phase 
chiral HPLC radiochromatography. A) Chromatogram of the 15-
C 4C]HETE that was produced in the incubation and then methylated before 
the chiral-phase chromatography shown here. B) Chromatogram of the 
same material to which racemic 15-C 4C]HETE methyl ester standard was 
added. C) Chromatogram of the 12-[14C]HETE that was produced in the 
incubation and then methylated before the chiral-phase chromatography 
shown here. D) Chromatogram of the same material to which racemic 
12-C 4C]HETE methyl ester standard was added. The S-enantiomers of both 
15- and 12-HETE were the first to elute on these chiral-phase columns. 
The w-6 derivative of linoleic acid, 13-HODE, was the principal 
monohydroxylated fatty acid product present in the skin scales of 
each patient. The concentration of free 13-HODE was 190 ± 103 
ng/mg scale lipid (mean ± SEM) in the samples derived from 
patients with non-psoriatic dermatoses and 894 ± 227 ng/mg scale 
lipid in the samples derived from the three patients with psoriasis 
(Table I). The difference in mean levels of 13-HODE between the 
group of non-psoriatic and the group of psoriatic scale extracts was 
statistically significant (p = 0.009) . The w-10 derivative of linoleic 
acid, 9-HODE, also was present in the skin scales of each patient. 
Its concentration was 36 ± 14 ng/mg scale lipid (mean ± SEM) in 
the samples from patients with non-psoriatic dermatoses and 258 ± 
53 ng/mg scale lipid in the samples from patients with psoriasis 
(p = 0.0001). 
Scales from the patients with drug-induced erythroderma and 
discoid lupus were incubated in vitro with C 4C]linoleic acid. The 
principal radioactive products eluted on reversed-phase HPLC at 
the retention times of both 13- and 9-HODE, which co-elute under 
these chromatographic conditions (Fig 1). These radioactive prod-
ucts were methylated, and the corresponding methyl esters resolved 
on straight- and chiral-phase HPLC. The predominant product in 
both incubations was the w-6 derivative, 13 (S)_[14C]HODE. The 
w-10 derivative, 9(S,R)-C4C]HODE, was produced in amounts 3% 
to 30% of that of 13(S)-C 4C]HODE (Fig 3). The regio- and 
stereochemical preferences of this w-6 oxygenase, the activity of 
which is preserved in skin scales, are identical to those described 
previously for human recombinant 15-lipoxygenase [13]. 
An analysis of the monohydroxylated linoleic acid derivatives in 
lipid extracts of skin scales provided evidence for their primary 
origin from the action of 15-lipoxygenase; however, variation in 
both the enantiopurity of 13-HODE and in the relative amounts of 
9-HODE suggested the additional contribution of a second oxyge-
nase andlor auto-oxidation. This is illustrated by analysis of the 
monohydroxylated linoleic acid derivatives present in the scales 
from a patient with erythroderma associated with an underlying 
lung cancer (Fig 4). The predominant product was 13(S)-HODE 
(SIR = 5.6); a small amount of 9-HODE (SIR = 0.5) also was 
evident but constituted only 13% of that of 13-HODE. These 
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Figure 3. 13(S)-HODE is the predominant product generated dur-
ing in vitro incubations of [14C]linoleic acid with skin scales. The 
outer radiochromatogram shows material that was extracted from the 
incubation of skin scales from a patient with drug-induced erythroderma, 
chromatographed on reversed-phase columns, methylated, and then rechro-
matographed on straight-phase columns before the chiral-phase chroma-
tography shown here. The inner chromatogram (inset) is the same material to 
which racemic 13-C 4C]HODE and 9-[14C]HODE methyl ester standards 
were added. The methyl ester of 13-HODE eluted before that of9-HODE, 
and the S-enantiomer of each compound was the first to elute under these 
chromatographic conditions. 
results are virtually identical to those observed when scales from the 
patient with drug-induced erythroderma were incubated ill vitro 
with C4 C]linoleic acid (Fig 3). In other scale extracts, the 13-
HODE had less enantiopurity, and the relative amount of9-HODE 
was greater (Table I) . The SIR ratios of 13-HODE ranged from 
1.4 to 6.0, and the amounts of9-HODE ranged from 13% to 100% 
of that of 13-HODE. In each sample, the R-enantiomer of 
9-HODE was predominant (SIR = 0.6 ± 0.1, mean ± SEM). 
13-HODE and 9-HODE were detected in both free and esteri-
fied form in each of the non-psoriatic and psoriatic skin-scale 
samples except in those obtained from the patients with seborrheic 
dermatitis, subacute cutaneous lupus, pemphigus foliaceus, and 
congenital ichthyosis. In the latter samples, only the free form of 
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150 2_ 
~ ::l a:: E E 
100 
1_ 
50 
0~---L~a.-&~ __ ~ 
42 65 TI ... (min.) Ttme (min.) 
Figure 4. 13(S)-HODE is the predominant monohydroxylated lino-
leic acid derivative formed in vivo and detected in lipid extracts of 
skin scales. In both straight-phase chiral HPLC chromatograms, the 
starting material was obtained from a patient with erythroderma secondary 
to an underlying lung cancer. Right: chromatogram representing the original 
material; left: the same material to which authentic racemic 13- and 
9-HODE methyl ester standards were added. The methyl ester of 13-
HODE eluted before that of 9-HODE, and the S-enantiomer of each 
compound was the first to elute under these chromatographic conditions. 
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these compounds was detected (data not shown). In the six 
non-psoriatic skin-scale samples, the amounts of free 13-HODE 
and 9-HODE exceeded those of esterified 13-HODE and 
9-HODE, respectively, by median factors of 11 (range, 3-132) and 
3 (range, 1-18). Esterified 13-HODE and 9-HODE were non-
racemic mixtures in five of these six samples, with SIR ratios of the 
non-racemic material being 1.6 ± 0.2 and 0.6 ± 0.04 (mean ± 
SEM), respectively. In the three psoriatic samples, the ratios offree 
to esterified 13-HODE and of free to esterified 9-HODE ranged 
from 15 to 19 and from 3 to 5, respectively. The average SIR ratios 
of the esterified 13-HODE and 9-HODE in the psoriatic samples 
were 1.5 ± 0.1 and 0.2 ± 0.1 (mean ± SEM) , respectively. 
15(S)-HETE was detected in esterified form in one of the three 
psoriatic scale samples and in two of the seven non-psoriatic scale 
samples. Esterified 12(R)-HETE was detected only in the scale 
sample obtained from the patient with erythroderma associated 
with cutaneous T-cell lymphoma. 
DISCUSSION 
In the current studies, identification of the positional and enantio-
meric isomers of fatty acid derivatives, formed either ill vivo from 
endogenous fatty acids and trapped in skin scales or generated ill 
vitro during incubation of scales with radiolabeled fatty acid sub-
strates, provided evidence as to the nature of the oxygenase 
responsible for their production. The findings support the conclu-
sion that there are at least two distinct oxygenases that are activated 
in a diverse spectrum of scaling dermatoses, including psoriasis. 
The first of these oxygenases is 15-lipoxygenase. 15(S)-HETE was 
detected in lipid extracts of the skin scales from patients with various 
scaling dermatoses and represented the product formed ill vivo from 
endogenous arachidonic acid. 15(S)-HETE also was generated in vitro 
during incubation of scales with arachidonic acid. These observations 
constitute strong evidence for the activation of 15-lipoxygenase in the 
epidermis of patients with these dermatoses . As a rule, the mammalian 
lipoxygenases demonstrate strict S-stereospecificity for oxygen inser-
tion at the chiral center carbon [14]. In contrast, cyclooxygenases in 
cultured human cells produce 15-HETE with SIR ratios of 1.5 to 3.5 
[15,16], and human hepatic cytochrome P450 monoxygenases pro-
duce predominantly 15(R)-HETE [17]. 
There are several cells within the epidermis or within inflamma-
tory infiltrates that possess 15-lipoxygenase activity. 15-lipoxyge-
nase activity has been identified in cultured human keratinocytes 
[18], eosinophils [19], and in monocytes cultured in the presence of 
interleukin-4 [20]. The extent of and the conditions necessary for 
the activation of the epidermal 15-lipoxygenase in vivo are not 
known [21]. Because 15(S)-HETE was identified in scales derived 
from a variety of skin lesions, ranging from cutaneous T-cell 
lymphoma to discoid lupus, in which there is variation as to the type 
of inflltrating inflammatory cell, it is most likely that the keratino-
cyte is the primary cell type expressing 15-lipoxygenase activity in 
inflammatory dermatoses. 
The identification ' of 12(R)-HETE in the psoriatic and non-
psoriatic scale extracts and the generation of 12(R)-C4 C]HETE 
during incubation of scales with [14C]arachidonic aci4 indicate the 
activation of an arachidonic 12(R)-oxygenase in various scaling 
dermatoses, not only psoriasis. The R-stereospecificity of this 
oxygenase indicates that it is not a lipoxygenase [14]. The findings 
of 12(R)-HETE and of an arachidonic acid 12(R)-oxygenase in skin 
scales contrast with findings in normal epidermis. Freshly isolated 
epidermal cells produce 12-HETE with predominant S-stereo-
specificity by a microsomal oxygenase activity, which includes the 
actions of a lipoxygenase [22,23] and of a cytochrome P450 
monooxygenase [24]. Despite the demonstration of the capacity of 
epidermal cells to produce 12(S)-HETE ill vitro, it is notable that 
this enantiomer of 12-HETB was not detected in the skin scales, 
suggesting that it is either not produced in vivo or is selectively 
metabolized prior to the formation of the corneocyte. 12-HETE is 
not a known product of cyclooxygenase. The only fatty acid 
oxygenase that has been associated to date with the production of 
12(R)-HETE is a cytochrome P450 monooxygenase [17,25]. In our 
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previous study of the arachidonic acid 12(R)-oxygenase in psoriatic 
skin scales, we observed that this enzyme activity was partially 
inhibited by nordihydroguaiaretic acid but not by indomethacin, 
carbon monoxide, or SKF-525A [8]. More studies are needed to 
define the nature of this arachidonic acid 12 (R)-oxygenase. 
In the current study, incubation of skin scales with radiolabeled 
linoleic acid resulted in the predominant production of 13(S)-
HODE, consistent with the activity of a 15-lipoxygenase, and the 
minor production of 9(R,S)-HODE. The products formed in vivo 
from endogenous linoleic acid and detected in the scale extracts 
were not always identical to those produced in vitro. In some 
samples, there were increased amounts of 13(R)-HODE and in-
creased amounts of9-HODE relative to that of 13-HODE. In these 
samples, the profile of linoleic acid products suggests the action of 
15-lipoxygenase and that of auto-oxidation and/or a second oxy-
genase, such as cyclooxygenase or a cytochrome P450 monooxy-
genase. When cyclooxygenase reacts with linoleic acid, both 
9(R,S)-HODE and 13(S,R)-HODE are formed, and 9-HODE is the 
predominant regioisomer [26]. Cytochrome P450 monooxygenases 
yield a variety of monohydroxylated products when reacting with 
linoleic acid; these include 18-, 17-, 11-, 9-, and 13-HODE. The R 
isomer constitutes 80% of the 9-HODE and of the 13-HODE pro-
duced by human hepatic cytochrome P450 monooxygenases [17]. 
Although the activation of 15-lipoxygenase and arachidonic acid 
12(R)-oxygenase is not a finding specific to psoriasis, the extent of 
this activation may be significantly greater in psoriasis. The levels of 
12-HETE, 13-HODE, and 9-HODE were each significantly higher 
in the psoriatic skin-scale samples than in the non-psoriatic scale 
samples. In addition, there was a 125-fold range in the levels of 
12-HETE and a 144- to 264-fold range in the levels of the 
15-lipoxygenase producb 15-HETE and 13-HODE in the skin 
scales (Table I). Of particular note was the overall concordance in 
the rank ordering of the levels of these different fatty acid deriva-
tives from sample to sample. This rank order of derivative levels 
tended to correlate positively with the expected severity of the 
epidermal inflammatory infiltrate in the various dermatoses. The 
levels were consistently highest in the samples from patients with 
psoriasis and those with erythroderma; the levels were low or not 
detectable in the samples taken from dermatoses such as pemphigus 
foliaceus, desquamation secondary to first-degree sunburn, and 
congenital ichthyosis, in which an inflammatory infiltrate within the 
epidermis may be absent or minimal. If scales are effective traps of 
lipid mediators produced earlier in the epidermal cell cycle, then 
levels of these mediators may in fact reflect the extent of epidermal 
oxygenase activation. In the current study, levels of the fatty acid 
derivatives were measured in single skin-scale specimens obtained 
from patients with diverse dermatoses. More studies will be re-
quired to ascertain the range and reproducibility of oxygenase 
product levels in specific dermatoses and to correlate these levels 
with the varying extent of inflammatory infiltrate and/or hyper-
proliferation observed in different dermatoses. 
The monohydroxylated fatty acid derivatives were found in both 
a free and an esterified form in skin scales. Although the principal 
esterified compounds were non-racemic 13(S,R)- and 9(R,S)-
HODE, in some cases, small amounts of 15(S)-HETE and 12(R)-
HETE could be demonstrated in esterified form as well. It has been 
demonstrated that cultured keratinocytes, which have a higher 
proportion of basaloid keratinocytes compared to normal epider-
mis, can esterify exogenous fatty acids into membrane lipids. This 
cell property is lost after the membrane is damaged by freeze-
thawing [18]. In contrast, the terminally differentiated buccal 
epithelial cell cannot incorporate exogenous fatty acids into mem-
brane lipids [6]. Thus, the ability to esterify monohydroxylated fatty 
acid derivatives appears to be a function of a less differentiated 
keratinocyte. The finding of fatty acid derivatives esterified in 
skin-scale lipids thus may indicate that these products are formed 
early in the differentiation program of the keratinocyte. These 
observations suggest that these oxygenase products may be formed 
as part of a pathophysiologic mechanism. 
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